Spondyloarthritis Among Patients With Uveitis: Can We Improve Referral Pathways?

J Rheumatol. 2022 May 15:jrheum.220263. doi: 10.3899/jrheum.220263. Online ahead of print.ABSTRACTDelays in diagnosis remain a major gap in the care of patients with axial spondyloarthritis (axSpA). Despite efforts to improve awareness among family physicians and nonrheumatologist specialists, the average duration from onset of symptoms to diagnosis of axSpA is approximately 8 years,1 which is one of the longest in rheumatology. Such delays in diagnosis are associated with late initiation of therapy and worse disease outcomes.PMID:35569829 | DOI:10.3899/jrheum.220263
Source: J Rheumatol - Category: Rheumatology Authors: Source Type: research
More News: Rheumatology